Skip to main content
. 2019 Jul 11;11(7):327. doi: 10.3390/pharmaceutics11070327

Figure 13.

Figure 13

Doxorubicin/mesoporous silica nanoparticles (MSN)-Gelatin-PEG nanoparticulate design.